Open AccessAurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
Author(s) -
Giovanni Martinelli,
Simona Soverini,
Ilaria Iacobucci,
Cristina Papayannidis,
Daniela Cilloni,
Michele Baccarani
Publication year - 2009
Publication title -
hematology reviews
Language(s) - English
Resource type - Journals
eISSN - 1970-6804
pISSN - 1970-6790
DOI - 10.4081/hr.v1i1.5
Subject(s) - medicine , imatinib , myeloid leukemia , chronic myelogenous leukemia , tyrosine kinase , cancer research , aurora kinase , nilotinib , dasatinib , philadelphia chromosome , leukemia , kinase , pharmacology , chromosomal translocation , cancer , biology , receptor , biochemistry , cell cycle , gene , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom